Merck Begins Offer For Cubist Shares In $8.4 Billion Deal

The drugmaker Merck is launching its previously-disclosed $8.4 billion offer to buy Cubist Pharmaceuticals shares in a deal that aims to strengthen its ability to treat serious infections, an issue drawing growing concern globally. … Click to Continue »

Topics:  merck   cubist pharmaceuticals    click   continue   offer   shares   billion   deal   
BING NEWS:
  • Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate
    Merck MRK has initiated phase III study on its oral KRAS G12C inhibitor candidate, MK-1084, for first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC).
    04/4/2024 - 10:33 pm | View Link
  • Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug
    For the deal, Merck made an upfront payment of $4 billion to Daiichi while being ... In the past year, shares of ADMA Biologics have risen 100%. Earnings of ADMA Biologics beat estimates in ...
    04/3/2024 - 10:36 pm | View Link
  • Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
    The drug, which will sell under the name Winrevair, treats a condition called pulmonary arterial hypertension that affects nearly 40,000 people in the U.S. In 2021, Merck paid $11.5 billion for ...
    03/26/2024 - 11:07 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News